Gut Microbiota in Pancreatic Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 196

Special Issue Editor


E-Mail Website
Guest Editor
Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy
Interests: nutrition; gut microbiota; nutraceuticals
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Gut microbiota alterations are found in pancreatic diseases and may play a role in the pathogenesis of several pancreatic diseases including acute pancreatitis, chronic pancreatitis and pancreatic cancer.

Much of the evidence that leads us to think that gut microbial dysbiosis contributes to the pathogenesis of pancreatic diseases comes from animal models. There are many variables involving the composition of the gut microbiota, such as diet, the use of drugs such as antibiotics and immunosuppressants, living environment, and genetics. It is necessary to clarify how the microbiota influences the development and course of pancreatic diseases by assessing the gut microbiome of patients at risk for pancreatic disease.

The aim of this Special Issue is to investigate possible correlations with pancreatic disease, as the targeted modulation of the microbiota could have therapeutic value in the prevention and treatment of pancreatic disease.

Dr. Giulia Pignataro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • pancreatic disease
  • pancreas
  • pancreatitis
  • pancreatic cancer
  • intestinal dysbiosis
  • pancreatic disease dysbiosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop